Arno Therapeutics, Inc 5
5 · Arno Therapeutics, Inc · Filed Feb 17, 2015
Insider Transaction Report
Form 5
Proniuk Stefan
VP of Product Development
Transactions
- Disposition to Issuer
2012 Series B Warrants (right to buy)
2014-10-28−8,333→ 0 totalExercise: $2.40From: 2013-10-29Exp: 2014-10-31→ Common Stock (8,333 underlying) - Award
2012 Series B Warrants (right to buy)
2014-10-28+8,333→ 8,333 totalExercise: $2.40From: 2013-10-29Exp: 2015-01-31→ Common Stock (8,333 underlying)
Holdings
- 10,047
Common Stock
Footnotes (1)
- [F1]The reported transaction resulted from the Issuer's unilateral extension of the expiration date of the outstanding warrant from 10/31/14 to 1/31/15. Such extension resulted in the deemed cancellation of the "originally" issued old warrant and the issuance of a replacement warrant. The Series B warrant was originally granted on 10/26/12.